-
The Time When Edward Snowden Showed Interest In Replacing Elon Musk As Twitter CEO: 'I Take Payment In Bitcoin'
Thursday, April 6, 2023 - 12:32am | 503Read More...Though Edward Snowden slammed Elon Musk a few weeks ago after Twitter blocked his wife’s account over her photo with their baby, there was a time when the former intelligence contractor expressed an interest in being the CEO of the social media platform. What Happened: In December 2022...
-
ICYMI: Costco Controversy, Dropbox IPO, Blockchain In Trucking
Thursday, March 15, 2018 - 10:31am | 249Read More...In case you missed it, here are some of Benzinga's top stories from Wednesday, March 14, 2018. Costco Called Out By Canada’s CBC CBC posted a trailer this week for an investigation into Costco Wholesale Corporation (NASDAQ: COST) and allegations the retailer pressured suppliers to make...
-
ICYMI: Micron, Teflon Tesla, BlueLinx Acquisition, Citron Vs. Netflix
Monday, March 12, 2018 - 5:04pm | 360Read More...In case you missed it, here are some of Benzinga's top stories from Monday, March 12, 2018. Nomura Doubles Down on Micron Micron Technology Inc (NASDAQ: MU) shares got a lift Monday as Nomura’s Romit Shah increased his price target on the stock to $100. Learn more about his thesis in...
-
ICYMI: Cigna And Express Scripts, AMD And Nvidia, Amazon And Wayfair
Thursday, March 8, 2018 - 5:49pm | 354Read More...In case you missed it, here are some of Benzinga's top stories from Thursday, March 8, 2018. The Latest Mega-Merger Cigna Corporation (NYSE: CI) announced it would acquire Express Scripts Holding Company (NASDAQ: ESRX) for about $96 a share in cash and stock. Take a look at the details, and...
-
ICYMI: Valeant, Overstock And Biotechs
Monday, March 5, 2018 - 7:35pm | 284Read More...In case you missed it, here are some of Benzinga's top stories from Monday, March 5, 2018. A Valeant Bear Relents Learn what finally convinced Deutsche Bank’s Gregg Gilbert to grant a buy rating to Valeant Pharmaceuticals Inc (NYSE: VRX) in Elizabeth Balboa’s “How Valeant...
-
ICYMI: Snapchat, Molecular Biotech's CEO Speaks, SEC Examines Crypto ICOs
Thursday, March 1, 2018 - 6:06pm | 282Read More...In case you missed it, here are some of Benzinga's top stories from Thursday, March 1, 2018. SEC Probes Crypto With headlines that briefly sent bitcoin and other digital currencies falling, the Wall Street Journal reported the SEC is investigating companies and advisers in the cryptocurrency...
-
ICYMI: MiMedx, Walmart Earnings, Strength In Steels, Bull Calls On PagSeguro
Tuesday, February 20, 2018 - 6:22pm | 404Read More...In case you missed it, here are some of Benzinga's top stories from Tuesday, Feb. 20, 2018. Walmart Woes Drag Down the Dow The retail sector, as well as the broader market, traded mostly lower Tuesday amid soft results from Walmart Inc (NYSE: WMT) in Q4. See what the sell-side pros thought of...
-
ICYMI: Bonds Hurt Stocks, GE's Doldrums, KODAKCoin
Thursday, February 15, 2018 - 6:00pm | 254Read More...In case you missed it, here are some of Benzinga's top stories from Thursday, Feb. 15, 2018. Bonds Vs. Stocks Have you wondered why the recent market volatility has been accompanied by so much mention of bond yields? Fear not, Wayne Duggan explains the correlation between rising yields and...
-
ICYMI: Uber Earnings, Fossil Short Squeeze, Avis Downgraded
Wednesday, February 14, 2018 - 6:29pm | 260Read More...In case you missed it, here are some of Benzinga's top stories from Wednesday, Feb. 14, 2018. Fossil Digs Up 80% Upside Shares of Fossil Group, Inc (NASDAQ: FOSL) spiked as high as 82 percent Wednesday after reporting a big Q4 top and bottom line beat. But the outsized upside was due to a...
-
ICYMI: Litecoin Cash, Lumber Liquidators Defended, Blockchain Hiring
Tuesday, February 13, 2018 - 6:34pm | 218Read More...In case you missed it, here are some of Benzinga's top stories from Tuesday, Feb. 13, 2018. Litecoin Cash Controversy Like bitcoin before it, Litecoin will soon have an unaffiliated crypto created by a fork in its blockchain, but some, including Litecoin creator Charlie Lee, are questioning...
-
ICYMI: Nvidia, Snap, The VIX, And MoviePass
Thursday, February 8, 2018 - 6:52pm | 450Read More...In case you missed it, here are some of Benzinga's top stories from Thursday, Feb. 8, 2018. Exclusive Interview With Helios and Matheson CEO Helios and Matheson Analytics Inc (NASDAQ: HMNY) CEO Ted Farnsworth took time to chat with Benzinga’s Brett Hershman in a revealing interview that...
-
ICYMI: Snap Earnings, VIX Instruments, AMD And Nvidia
Thursday, February 8, 2018 - 10:02am | 301Read More...In case you missed it, here are some of Benzinga's top stories from Wednesday, Feb. 7, 2018. Snap Pops On Earnings Does one good quarter make Snap Inc (NYSE: SNAP) stock worth buying? Apparently so, in Bank of America’s view. See what has the sell-side firm so bullish on the camera...
-
ICYMI: The Inverse VIX ETN Bloodbath
Tuesday, February 6, 2018 - 6:17pm | 372Read More...In case you missed it, here are some of Benzinga's top stories from Tuesday, February 6th, 2018. The Inverse Volatility ETN Everyone’s Talking About Todd Shriber examines the tumble taken by VelocityShares Daily Inverse VIX Short-Term ETN (NASDAQ: XIV). Check out “It's Going...
-
ICYMI: Kroger Rumors, NBA Gambling, Apple's Q1, Blockchain ETF
Thursday, January 25, 2018 - 6:27pm | 370Read More...In case you missed it, here are some of Benzinga's top stories from Thursday, Jan. 25, 2018. Blockchain ETF, One Week In After a week of trading, interest remains high in the only blockchain ETFs, Reality Shares Nasdaq NextGen (NASDAQ: BLCN) and Amplify Transformational Data (NYSE: BLOK)....
-
ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call
Wednesday, January 24, 2018 - 6:20pm | 284Read More...In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 24, 2018. A Pharma Trade From Goldman Jayson Derrick outlines a bull and bear call on Catelent, Inc (NYSE: CTLT) and Valeant Pharmaceuticals International, Inc (NYSE: VRX), respectively, from Goldman Sachs....
